Annual Total Long Term Liabilities
$7.36 M
-$6.69 M-47.60%
December 31, 2023
Summary
- As of February 20, 2025, CUE annual total long term liabilities is $7.36 million, with the most recent change of -$6.69 million (-47.60%) on December 31, 2023.
- During the last 3 years, CUE annual total long term liabilities has risen by +$3.06 million (+71.00%).
- CUE annual total long term liabilities is now -47.60% below its all-time high of $14.05 million, reached on December 31, 2022.
Performance
CUE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2.65 M
-$1.59 M-37.52%
September 30, 2024
Summary
- As of February 20, 2025, CUE quarterly total long term liabilities is $2.65 million, with the most recent change of -$1.59 million (-37.52%) on September 30, 2024.
- Over the past year, CUE quarterly long term liabilities has dropped by -$1.59 million (-37.52%).
- CUE quarterly long term liabilities is now -84.08% below its all-time high of $16.67 million, reached on June 30, 2022.
Performance
CUE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CUE Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.6% | -37.5% |
| 3 y3 years | +71.0% | -81.1% |
| 5 y5 years | +42.3% | -81.1% |
CUE Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -47.6% | +43.8% | -84.1% | at low |
| 5 y | 5-year | -47.6% | +71.0% | -84.1% | -100.0% |
| alltime | all time | -47.6% | -100.0% | -84.1% | -100.0% |
Cue Biopharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.65 M(-37.5%) |
| Jun 2024 | - | $4.25 M(-27.0%) |
| Mar 2024 | - | $5.82 M(-20.9%) |
| Dec 2023 | $7.36 M(-47.6%) | $7.36 M(-18.3%) |
| Sep 2023 | - | $9.02 M(-16.9%) |
| Jun 2023 | - | $10.85 M(-15.6%) |
| Mar 2023 | - | $12.86 M(-8.5%) |
| Dec 2022 | $14.05 M(+174.4%) | $14.05 M(-8.2%) |
| Sep 2022 | - | $15.31 M(-8.1%) |
| Jun 2022 | - | $16.67 M(+14.0%) |
| Mar 2022 | - | $14.62 M(+185.5%) |
| Dec 2021 | $5.12 M(+18.9%) | $5.12 M(>+9900.0%) |
| Sep 2021 | - | $0.00(-100.0%) |
| Jun 2021 | - | $89.00 K(-96.3%) |
| Mar 2021 | - | $2.42 M(-43.8%) |
| Dec 2020 | $4.31 M | $4.31 M(-11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $4.84 M(-23.7%) |
| Jun 2020 | - | $6.34 M(+90.7%) |
| Mar 2020 | - | $3.32 M(-38.1%) |
| Dec 2019 | $5.37 M(+3.7%) | $5.37 M(-31.2%) |
| Sep 2019 | - | $7.79 M(-23.6%) |
| Jun 2019 | - | $10.21 M(+3.3%) |
| Mar 2019 | - | $9.88 M(+90.9%) |
| Dec 2018 | $5.17 M(>+9900.0%) | $5.17 M(+772.6%) |
| Sep 2018 | - | $593.00 K(-35.5%) |
| Jun 2018 | - | $919.00 K(>+9900.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $36.40 K(+6.7%) | $36.40 K |
| Dec 2015 | $34.10 K | - |
FAQ
- What is Cue Biopharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Cue Biopharma?
- What is Cue Biopharma annual total long term liabilities year-on-year change?
- What is Cue Biopharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Cue Biopharma?
- What is Cue Biopharma quarterly long term liabilities year-on-year change?
What is Cue Biopharma annual total long term liabilities?
The current annual total long term liabilities of CUE is $7.36 M
What is the all time high annual total long term liabilities for Cue Biopharma?
Cue Biopharma all-time high annual total long term liabilities is $14.05 M
What is Cue Biopharma annual total long term liabilities year-on-year change?
Over the past year, CUE annual total long term liabilities has changed by -$6.69 M (-47.60%)
What is Cue Biopharma quarterly total long term liabilities?
The current quarterly long term liabilities of CUE is $2.65 M
What is the all time high quarterly long term liabilities for Cue Biopharma?
Cue Biopharma all-time high quarterly total long term liabilities is $16.67 M
What is Cue Biopharma quarterly long term liabilities year-on-year change?
Over the past year, CUE quarterly total long term liabilities has changed by -$1.59 M (-37.52%)